Cleared Traditional

K852784 - ALKALINE PHOSPHATASE

K852784 is the FDA 510(k) clearance for ALKALINE PHOSPHATASE by Advanced Biomedical Methods, Inc.. It is a Class 2 Chemistry device (product code CJE) cleared through the Traditional 510(k) pathway after a 21-day FDA review.

K852784 · Advanced Biomedical Methods, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 1985
Decision
21d
Days
Class 2
Risk

K852784 is an FDA 510(k) clearance for the ALKALINE PHOSPHATASE. Classified as Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes (product code CJE), Class II - Special Controls.

Submitted by Advanced Biomedical Methods, Inc. (Niles, US). The FDA issued a Cleared decision on July 22, 1985 after a review of 21 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1050 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Advanced Biomedical Methods, Inc. devices

Submission Details

510(k) Number K852784 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 1985
Decision Date July 22, 1985
Days to Decision 21 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d faster than avg
Panel avg: 88d · This submission: 21d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CJE Nitrophenylphosphate, Alkaline Phosphatase Or Isoenzymes

All 86
Devices cleared under the same product code (CJE) and FDA review panel - the closest regulatory comparables to K852784.
EASY-TEST ALKALINE PHOSPHATASE (ALP) REAGENT
K860134 · Em Diagnostic Systems, Inc. · Feb 1986
IN VITRO TESTS FOR PHOSPHATASE & BLOOD NITROGEN
K852441 · Clinical Data, Inc. · Aug 1985
AMRESCO FLOW PAC ALKALINE PHOSPHATASE BUFFER CONCE
K852752 · American Research Products Co. · Jul 1985
ALP(ALKALINE)(PHOSPHATASE) REAGENT
K851998 · Alpkem Corp. · May 1985
VISION -FORMERLY PDA- ALKALINE PHOSPHATASE
K850110 · Abbott Laboratories · Jan 1985
SYSTEMATE ALKALINE PHOSPHATASE-67203
K843270 · Em Diagnostic Systems, Inc. · Sep 1984